The UK’s life sciences sector is getting a £520m boost for manufacturing 🧬
This will increase preparedness for future health emergencies like the COVID-19 pandemic and further strengthen research and development across the UK 🔬
Read more 🔽
Exclusive: Buried in the online autumn statement is a bit of news with potentially huge implications for biopharma.
The UK is going to try to create a pathway for individually customised medicines!
@mhra
@stopbatten
@GenomicsEngland
@OHRareDisease
The Government's response to Paul Nurse's review of the R&D landscape in the UK has just been published.
A few things that caught my eye on a first read through 🧵
Today is a very exciting day. The UK government announced in the Autumn Statement by Chancellor Jeremy Hunt, their support for the individualized medicines pilot MMF initiated over a year ago with support from Daniel O'Connor
@parkermoss
@Rich_Genomics
@nicolablackwood
@timyu
3.5m people in the UK live with a rare disease. 75% are children.
But under 10% of rare diseases have an approved treatment.
We must fix this.
As Chair of
@GenomicsEngland
I am delighted
@Jeremy_Hunt
announced the Rare Therapies Launch Pad today.
Info here👇👇
We are delighted to announce the launch of the Rare Therapies Launch Pad, a new programme that aims to develop a pathway for children with rare conditions to access therapies made specifically for them. Read more here:
It was great to join you
@SFatumo
and such a brilliant Plenary Table
@Falling_Walls
Science this evening. With so much pressure on health systems - gathering evidence for & demonstrating effective implementation for precision prevention has never been more important!
I pray for the peace of Israel. I condemn the terrible acts of terror Hamas are inflicting on civilians. Tonight Israeli flag flies
@10DowningStreet
, Berlin, NYC, EU Commission. We
#StandWithIsrael
.
@GoogleDeepMind
’s AI is now helping scientists speeds up the search for disease genes.
@ewanbirney
tells me
#AI
is “changing nearly everything in molecular biology”.
Excited that we’re announcing today our
@genomicsengland
partnership with
@nanopore
to Long-Read sequence 7,500 rare disease participants in order to increase diagnostic rates and treatment opportunities 🧬 🚀
Excited to share
#AlphaMissense
our new AI system that can classify whether genetic mutations (missense variants) are benign or harmful - a critical step toward uncovering causes of many diseases, from cystic fibrosis to cancer. In
@ScienceMagazine
today
Fantastic
@GenomicsEngland
Research Summit - celebrating great progress & vital clinical impact genomics has now but also clarion call to press on & realise full potential
Thanks to all our amazing partners
#NHS
, participants, researchers, industry. See you next year!
#GERS2023
The
@turinginst
2022-23 annual report is released today, and it gives me great pleasure to introduce the Turing’s research highlights of the year – just a taste of our successes in 2022-23.
We propose:
- Funding research for better model evaluations
- Developing risk-responsive capabilities assessments
- Establishing pre-registration for large training runs
- Empowering technically literate auditors
- Mandating red teaming before model release